Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2015 08:01 ET | Source: TESARO, Inc.

TESARO Announces Participation at Three Investor Conferences

WALTHAM, Mass., April 22, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three investor conferences during the...
April 16, 2015 08:01 ET | Source: TESARO, Inc.

TESARO to Announce First-Quarter Financial Results on April 30, 2015

WALTHAM, Mass., April 16, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) will announce its first-quarter 2015 financial results on Thursday, April 30, 2015, after the close of the U.S. financial...
April 14, 2015 08:01 ET | Source: TESARO, Inc.

TESARO Announces Upcoming Immuno-Oncology Presentations

WALTHAM, Mass., April 14, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced two upcoming presentations related to its immuno-oncology...
April 09, 2015 08:15 ET | Source: TESARO, Inc.

TESARO Announces Nomination of Garry A. Nicholson for Election to Board of Directors

WALTHAM, Mass., April 9, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced the nomination of Garry A. Nicholson for election to the...
March 31, 2015 07:01 ET | Source: TESARO, Inc.

TESARO Appoints Joseph Farmer, as Senior Vice President, General Counsel and Secretary

WALTHAM, Mass., March 31, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, today announced the appointment of Joseph L. Farmer as Senior Vice...
March 09, 2015 16:01 ET | Source: TESARO, Inc.

TESARO Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option by Underwriters

WALTHAM, Mass., March 9, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) today announced the closing of its previously announced underwritten public offering of common stock. TESARO sold 3,755,000...
March 05, 2015 08:00 ET | Source: TESARO, Inc.

TESARO to Present at the Barclays Global Healthcare Conference

WALTHAM, Mass., March 5, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the Barclays Global Healthcare...
March 03, 2015 22:00 ET | Source: TESARO, Inc.

TESARO Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass., March 3, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has priced an underwritten public offering of an aggregate of 3,400,000 shares of its common stock...
March 02, 2015 16:05 ET | Source: TESARO, Inc.

TESARO Announces Proposed Public Offering of Common Stock

WALTHAM, Mass., March 2, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has commenced an underwritten public offering of $150 million of its common stock. In connection...
February 19, 2015 16:01 ET | Source: TESARO, Inc.

TESARO Announces Fourth-Quarter 2014 Operating Results

Enrollment in niraparib NOVA non-gBRCA cohort on track to complete during Q1 2015 New QUADRA trial of niraparib for the treatment of ovarian cancer to begin in Q1 2015 U.S. FDA PDUFA...